Obesity and Menopausal Status in Breast Cancer
Clifford A. Hudis, MD, discusses obesity and menopausal status as determinants of procarcinogenic breast inflammation.
Clinical Pearls
Clifford A. Hudis, MD, Chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses obesity and menopausal status as determinants of procarcinogenic breast inflammation.
- The peak incidence of hormone-sensitive breast cancer occurs in the decade after menopause.
- There is an association between hormone-sensitive breast cancer and obesity.
- Some of the inflammatory mediators that are generated in the fat tissue of obese patients are stimulants for the production of aromatase, and thereby, estrogen.
- Predictors of these inflammatory mediators in the breast include both obesity and the postmenopausal state. This suggests that after menopause, there is a low-grade, chronic systemic inflammation in some people that may contribute to postmenopausal breast cancer.
<<<
Rugo Surveys Peers on Treatment After Metastatic Relapse of HR+, HER2– Breast Cancer
April 20th 2024During a Case-Based Roundtable® event, Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
PTCy Offers New Hope for Mismatched Stem Cell Transplants in Leukemia, MDS
April 13th 2024Jeff Auletta, MD, discussed how PTCy-based graft-vs-host disease prophylaxis offers a promising approach for expanding access to successful cell transplantation regardless of donor match or patient ethnicity.
Read More
